Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-ba...
Saved in:
Published in | BMC health services research Vol. 23; no. 1; p. 512 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
20.05.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context.
Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses.
Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective.
Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. |
---|---|
AbstractList | Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context. Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses. Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective. Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. Abstract Background Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context. Methods Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses. Results Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective. Conclusion Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context. Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses. Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective. Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. BackgroundTraditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context.MethodsFollowing a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses.ResultsTelerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective.ConclusionHybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. Background Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context. Methods Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses. Results Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective. Conclusion Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. Keywords: Cardiac rehabilitation, Hybrid, Cost-effectiveness, Telerehabilitation |
ArticleNumber | 512 |
Audience | Academic |
Author | Senanayake, Sameera Halahakone, Ureni McPhail, Steven M Tom Briffa McCreanor, Victoria Kularatna, Sanjeewa Redfern, Julie Parsonage, William Abell, Bridget |
Author_xml | – sequence: 1 givenname: Sameera surname: Senanayake fullname: Senanayake, Sameera email: s2.senanayake@qut.edu.au organization: Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia. s2.senanayake@qut.edu.au – sequence: 2 givenname: Ureni surname: Halahakone fullname: Halahakone, Ureni organization: Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia – sequence: 3 givenname: Bridget surname: Abell fullname: Abell, Bridget organization: Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia – sequence: 4 givenname: Sanjeewa surname: Kularatna fullname: Kularatna, Sanjeewa organization: Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia – sequence: 5 givenname: Victoria surname: McCreanor fullname: McCreanor, Victoria organization: Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia – sequence: 6 givenname: Steven M surname: McPhail fullname: McPhail, Steven M organization: Digital Health and Informatics, Metro South Health, Brisbane, QLD, Australia – sequence: 7 givenname: Julie surname: Redfern fullname: Redfern, Julie organization: The George Institute for Global Health, University of New South Wales, Sydney, Australia – sequence: 8 surname: Tom Briffa fullname: Tom Briffa organization: School of Population and Global Health, University of Western Australia, Perth, Australia – sequence: 9 givenname: William surname: Parsonage fullname: Parsonage, William organization: Royal Brisbane and Women's Hospital, Metro North Health, Herston, QLD, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37208666$$D View this record in MEDLINE/PubMed |
BookMark | eNptUk1v1DAQjVAR_YA_wAFF4sIlxXYSO-aCVhXQSpW4wNka2-OtV1m72Emr_fc43VK6CFnWWOP33njG77Q6CjFgVb2l5JzSgX_MlEnaNoSVLfuON_cvqhPaCdZwydujZ-fj6jTnDSFUDEy8qo5bwcjAOT-p_OVOJ29rA8l6MPWEIya8Ae1HP8HkY6hdTLWJKQZIuxrShCVYnxEy1j7UqzlPCUYPn2oouDw16Byayd9hwJxrCDDuss-vq5cOxoxvHuNZ9fPrlx8Xl831929XF6vrxvS8m5qBSmml7ZxwhIBwrUbdGkuNZIZIcLp3A-k4GuIGtFJzTbSkFrUVgnVOt2fV1V7XRtio2-S35d0qglcPiZjWqjThzYhKEklRMC0k5510dDAgObq2FUT0PfRF6_Ne63bWW7QGw9LqgejhTfA3ah3vFCVUDqJvi8KHR4UUf82YJ7X12eA4QsA4Z8UGykU_SLIUe_8PdBPnVKa3oJggTErJ_qLWUDrwwcVS2CyiaiW6gijf3RXU-X9QZVncelNs5HzJHxDYnmBSzDmhe2qSErW4Te3dporb1IPb1H0hvXs-nifKH3u1vwH0ENM4 |
CitedBy_id | crossref_primary_10_3390_electronics13020272 crossref_primary_10_4070_kcj_2023_0242 |
Cites_doi | 10.1016/j.pcad.2021.12.004 10.1007/s11886-021-01543-x 10.1097/HCR.0b013e31818c3b5b 10.1093/ehjdh/ztaa005 10.5694/j.1326-5377.2003.tb05588.x 10.1080/09593985.2019.1620388 10.1177/1178632922109103 10.1177/2047487319827453 10.1016/j.hlc.2022.07.006 10.1089/jwh.2016.6249 10.1332/174426410X482999 10.1007/s40273-017-0585-2 10.1093/ehjdh/ztab091 10.1136/bmjopen-2020-038178 10.1136/openhrt-2017-000623 10.1161/CIRCULATIONAHA.117.029471 10.1186/s12913-021-07414-z 10.1016/j.ahj.2009.08.010 10.1186/s12913-022-07667-2 10.1093/eurjcn/zvab118 10.1177/1179546817710028 10.1016/j.hlc.2018.11.010 10.1007/s12471-020-01432-y 10.1093/eurheartj/ehab484 10.1136/bmjopen-2019-032279 10.1177/2047487315602257 10.1177/2047487317732274 10.1001/archinte.163.22.2775 10.1001/jamanetworkopen.2021.36652 10.1136/heartjnl-2015-308966 10.1177/2047487314535076 10.1136/heartjnl-2014-305783 10.1016/j.hlc.2019.03.015 10.33963/kp.15885 10.1136/openhrt-2015-000374 10.1007/s11606-022-07481-w 10.1177/1474515119826510 10.1016/j.hlc.2022.06.493 10.1161/JAHA.120.021356 10.1177/2047487319878958 10.1136/heartjnl-2017-312809 10.1136/bmjopen-2021-054558 10.1002/14651858.CD001800.pub4 10.1136/heartjnl-2018-313189 10.1186/s12933-021-01292-9 |
ContentType | Journal Article |
Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7WY 7WZ 7X7 7XB 87Z 88C 88E 8FI 8FJ 8FK 8FL ABUWG AFKRA AZQEC BENPR BEZIV CCPQU COVID DWQXO FRNLG FYUFA F~G GHDGH K60 K6~ K9. KB0 L.- M0C M0S M0T M1P NAPCQ PIMPY PQBIZ PQBZA PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1186/s12913-023-09546-w |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database ABI/INFORM Collection ABI/INFORM Global (PDF only) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ABI/INFORM Global (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ABI/INFORM Collection (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest Business Premium Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Business Premium Collection (Alumni) Health Research Premium Collection ABI/INFORM Global (Corporate) Health Research Premium Collection (Alumni) ProQuest Business Collection (Alumni Edition) ProQuest Business Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ABI/INFORM Professional Advanced ABI/INFORM Global Health & Medical Collection (Alumni Edition) Health Management Database (Proquest) Medical Database Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Business ProQuest One Business (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ABI/INFORM Global (Corporate) ProQuest Business Collection (Alumni Edition) ProQuest One Business ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China ABI/INFORM Complete ProQuest Central ABI/INFORM Professional Advanced Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ABI/INFORM Complete (Alumni Edition) Business Premium Collection ABI/INFORM Global ABI/INFORM Global (Alumni Edition) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Business Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest One Business (Alumni) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) Business Premium Collection (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1472-6963 |
EndPage | 512 |
ExternalDocumentID | oai_doaj_org_article_9091e72b796649f18ca96ef3370755a5 A749929634 10_1186_s12913_023_09546_w 37208666 |
Genre | Journal Article |
GeographicLocations | Australia |
GeographicLocations_xml | – name: Australia |
GrantInformation_xml | – fundername: Australian Government National Health and Medical Research Council (NHMRC) Investigator Grant grantid: GNT1143538 – fundername: SOLVE-CHD Australian Government National Health and Medical Research Council (NHMRC) Synergy Grant grantid: GNT1182301 – fundername: ; grantid: GNT1182301; GNT1182301 – fundername: ; grantid: GNT1143538 |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 44B 53G 5VS 6J9 6PF 7RV 7WY 7X7 88E 8FI 8FJ 8FL AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACRMQ ADBBV ADINQ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BEZIV BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EMB EMK EMOBN ESX F5P FRNLG FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC K60 K6~ KQ8 M0C M0T M1P M48 M~E NAPCQ NPM O5R O5S OK1 P2P PGMZT PIMPY PQBIZ PQBZA PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION 7XB 8FK ACUHS AZQEC COVID K9. L.- PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c564t-8199d9d4f7f00a7f3beb3cd1c92c09afb5f8046ec0f8ed9b6b0b91debd7724fb3 |
IEDL.DBID | RPM |
ISSN | 1472-6963 |
IngestDate | Tue Oct 22 15:16:11 EDT 2024 Tue Sep 17 21:32:21 EDT 2024 Fri Oct 25 09:33:52 EDT 2024 Wed Dec 18 16:53:53 EST 2024 Tue Nov 19 20:57:54 EST 2024 Tue Nov 12 23:31:45 EST 2024 Thu Nov 21 23:19:48 EST 2024 Sat Sep 28 08:17:56 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Hybrid Telerehabilitation Cost-effectiveness Cardiac rehabilitation |
Language | English |
License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-8199d9d4f7f00a7f3beb3cd1c92c09afb5f8046ec0f8ed9b6b0b91debd7724fb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198753/ |
PMID | 37208666 |
PQID | 2827029992 |
PQPubID | 44821 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9091e72b796649f18ca96ef3370755a5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10198753 proquest_miscellaneous_2816758905 proquest_journals_2827029992 gale_infotracmisc_A749929634 gale_infotracacademiconefile_A749929634 crossref_primary_10_1186_s12913_023_09546_w pubmed_primary_37208666 |
PublicationCentury | 2000 |
PublicationDate | 2023-05-20 |
PublicationDateYYYYMMDD | 2023-05-20 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC health services research |
PublicationTitleAlternate | BMC Health Serv Res |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | M Varnfield (9546_CR28) 2014; 100 R Hwang (9546_CR22) 2019; 28 MJ Vale (9546_CR44) 2003; 163 S Bakhshayeh (9546_CR9) 2019 I Shemilt (9546_CR32) 2010; 6 A Abreu (9546_CR45) 2019; 26 C Giuliano (9546_CR11) 2017; 11 9546_CR38 9546_CR37 I Frederix (9546_CR25) 2016; 23 CM Astley (9546_CR27) 2022; 22 SL Grace (9546_CR4) 2021; 23 Australian Institute of Health and Welfare (9546_CR35) 2018 9546_CR30 VM Mehra (9546_CR1) 2020; 27 Australian Bureau of Statistics (9546_CR34) 2022 RWM Brouwers (9546_CR14) 2020; 28 D Gurewich (9546_CR10) 2008; 28 K Gergen Barnett (9546_CR50) 2022; 37 C Astley (9546_CR46) 2022; 22 S Cartledge (9546_CR53) 2019; 9 C Taylor (9546_CR48) 2017; 4 M Niewada (9546_CR41) 2021; 79 M Falter (9546_CR17) 2021; 3 M Scherrenberg (9546_CR21) 2020; 1 I Frederix (9546_CR26) 2020; 24 G Dibben (9546_CR2) 2021 S Cartledge (9546_CR16) 2022; 21 B Abell (9546_CR47) 2016; 3 AL Beatty (9546_CR5) 2018; 137 JR Medina-Inojosa (9546_CR49) 2021; 10 SM Dunlay (9546_CR12) 2009; 158 S Cartledge (9546_CR15) 2022; 31 R Główczyńska (9546_CR43) 2021; 20 DM Resurreccion (9546_CR8) 2017; 26 GE Shields (9546_CR20) 2018; 104 CM Astley (9546_CR6) 2020; 29 A Beleigoli (9546_CR51) 2022; 12 K Jin (9546_CR18) 2019; 18 R Maddison (9546_CR24) 2015; 22 R Maddison (9546_CR23) 2019; 105 Australian Institute of Health Welfare (9546_CR36) 2021 S Kularatna (9546_CR39) 2022; 15 LC Edney (9546_CR40) 2018; 36 IA Scott (9546_CR7) 2003; 179 9546_CR29 RW Brouwers (9546_CR42) 2021; 4 B Heindl (9546_CR19) 2021 FL Visseren (9546_CR3) 2021; 42 JC Rawstorn (9546_CR13) 2016; 102 J BA Lefkovits (9546_CR31) 2021 L Gao (9546_CR52) 2020; 10 Independent Hospital Pricing Authority (9546_CR33) 2022 |
References_xml | – year: 2021 ident: 9546_CR19 publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2021.12.004 contributor: fullname: B Heindl – volume: 23 start-page: 1 year: 2021 ident: 9546_CR4 publication-title: Curr Cardiol Rep doi: 10.1007/s11886-021-01543-x contributor: fullname: SL Grace – volume: 28 start-page: 380 year: 2008 ident: 9546_CR10 publication-title: J Cardiopulm Rehabil Prev doi: 10.1097/HCR.0b013e31818c3b5b contributor: fullname: D Gurewich – volume: 1 start-page: 20 year: 2020 ident: 9546_CR21 publication-title: Eur Heart J Digit Health doi: 10.1093/ehjdh/ztaa005 contributor: fullname: M Scherrenberg – volume: 179 start-page: 341 year: 2003 ident: 9546_CR7 publication-title: Med J Aust doi: 10.5694/j.1326-5377.2003.tb05588.x contributor: fullname: IA Scott – year: 2019 ident: 9546_CR9 publication-title: Physiother Theory Pract doi: 10.1080/09593985.2019.1620388 contributor: fullname: S Bakhshayeh – volume: 15 start-page: 117863292210910 year: 2022 ident: 9546_CR39 publication-title: Health Serv insights doi: 10.1177/1178632922109103 contributor: fullname: S Kularatna – volume: 26 start-page: 1131 year: 2019 ident: 9546_CR45 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487319827453 contributor: fullname: A Abreu – ident: 9546_CR29 doi: 10.1016/j.hlc.2022.07.006 – ident: 9546_CR37 – volume: 26 start-page: 849 year: 2017 ident: 9546_CR8 publication-title: J Womens Health doi: 10.1089/jwh.2016.6249 contributor: fullname: DM Resurreccion – volume: 6 start-page: 51 year: 2010 ident: 9546_CR32 publication-title: Evid Policy doi: 10.1332/174426410X482999 contributor: fullname: I Shemilt – volume: 36 start-page: 239 year: 2018 ident: 9546_CR40 publication-title: Pharmacoeconomics doi: 10.1007/s40273-017-0585-2 contributor: fullname: LC Edney – volume: 3 start-page: 67 year: 2021 ident: 9546_CR17 publication-title: Eur Heart J doi: 10.1093/ehjdh/ztab091 contributor: fullname: M Falter – volume: 10 start-page: e038178 year: 2020 ident: 9546_CR52 publication-title: BMJ open doi: 10.1136/bmjopen-2020-038178 contributor: fullname: L Gao – volume: 4 start-page: e000623 year: 2017 ident: 9546_CR48 publication-title: Open Heart doi: 10.1136/openhrt-2017-000623 contributor: fullname: C Taylor – volume-title: Admitted patient care 2016–17: Australian hospital statistics year: 2018 ident: 9546_CR35 contributor: fullname: Australian Institute of Health and Welfare – volume: 137 start-page: 1899 year: 2018 ident: 9546_CR5 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.029471 contributor: fullname: AL Beatty – volume: 22 start-page: 1 year: 2022 ident: 9546_CR46 publication-title: BMC Health Serv Res doi: 10.1186/s12913-021-07414-z contributor: fullname: C Astley – volume: 158 start-page: 852 year: 2009 ident: 9546_CR12 publication-title: Am Heart J doi: 10.1016/j.ahj.2009.08.010 contributor: fullname: SM Dunlay – volume: 22 start-page: 267 year: 2022 ident: 9546_CR27 publication-title: BMC Health Serv Res doi: 10.1186/s12913-022-07667-2 contributor: fullname: CM Astley – ident: 9546_CR30 – volume: 21 start-page: 548 year: 2022 ident: 9546_CR16 publication-title: Eur J Cardiovasc Nurs doi: 10.1093/eurjcn/zvab118 contributor: fullname: S Cartledge – volume-title: The Victorian Cardiac Outcomes Registry Annual Report 2021 year: 2021 ident: 9546_CR31 contributor: fullname: J BA Lefkovits – volume: 11 start-page: 117954681771002 year: 2017 ident: 9546_CR11 publication-title: Clin Med Insights doi: 10.1177/1179546817710028 contributor: fullname: C Giuliano – ident: 9546_CR38 – volume: 28 start-page: 1795 year: 2019 ident: 9546_CR22 publication-title: Heart Lung Circ doi: 10.1016/j.hlc.2018.11.010 contributor: fullname: R Hwang – volume: 28 start-page: 443 year: 2020 ident: 9546_CR14 publication-title: Neth Hear J doi: 10.1007/s12471-020-01432-y contributor: fullname: RWM Brouwers – volume: 42 start-page: 3227 year: 2021 ident: 9546_CR3 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab484 contributor: fullname: FL Visseren – volume: 9 start-page: e032279 year: 2019 ident: 9546_CR53 publication-title: BMJ Open doi: 10.1136/bmjopen-2019-032279 contributor: fullname: S Cartledge – volume-title: Heart, stroke and vascular disease—Australian facts year: 2021 ident: 9546_CR36 contributor: fullname: Australian Institute of Health Welfare – volume: 23 start-page: 674 year: 2016 ident: 9546_CR25 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487315602257 contributor: fullname: I Frederix – volume: 24 start-page: 1708 year: 2020 ident: 9546_CR26 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487317732274 contributor: fullname: I Frederix – volume: 163 start-page: 2775 year: 2003 ident: 9546_CR44 publication-title: Arch Internal Med doi: 10.1001/archinte.163.22.2775 contributor: fullname: MJ Vale – volume: 4 start-page: e2136652 year: 2021 ident: 9546_CR42 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.36652 contributor: fullname: RW Brouwers – volume: 102 start-page: 1183 year: 2016 ident: 9546_CR13 publication-title: Heart doi: 10.1136/heartjnl-2015-308966 contributor: fullname: JC Rawstorn – volume: 22 start-page: 701 year: 2015 ident: 9546_CR24 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487314535076 contributor: fullname: R Maddison – volume: 100 start-page: 1770 year: 2014 ident: 9546_CR28 publication-title: Heart doi: 10.1136/heartjnl-2014-305783 contributor: fullname: M Varnfield – volume: 29 start-page: 475 year: 2020 ident: 9546_CR6 publication-title: Heart Lung Circ doi: 10.1016/j.hlc.2019.03.015 contributor: fullname: CM Astley – volume: 79 start-page: 510 year: 2021 ident: 9546_CR41 publication-title: Kardiol Pol doi: 10.33963/kp.15885 contributor: fullname: M Niewada – volume: 3 start-page: e000374 year: 2016 ident: 9546_CR47 publication-title: Open Heart doi: 10.1136/openhrt-2015-000374 contributor: fullname: B Abell – volume: 37 start-page: 2845 year: 2022 ident: 9546_CR50 publication-title: J Gen Internal Med doi: 10.1007/s11606-022-07481-w contributor: fullname: K Gergen Barnett – volume: 18 start-page: 260 year: 2019 ident: 9546_CR18 publication-title: Eur J Cardiovasc Nurs doi: 10.1177/1474515119826510 contributor: fullname: K Jin – volume: 31 start-page: S290 year: 2022 ident: 9546_CR15 publication-title: Heart Lung Circ doi: 10.1016/j.hlc.2022.06.493 contributor: fullname: S Cartledge – volume: 10 start-page: e021356 year: 2021 ident: 9546_CR49 publication-title: J Am Heart Assoc. doi: 10.1161/JAHA.120.021356 contributor: fullname: JR Medina-Inojosa – volume: 27 start-page: 912 year: 2020 ident: 9546_CR1 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487319878958 contributor: fullname: VM Mehra – volume: 104 start-page: 1403 year: 2018 ident: 9546_CR20 publication-title: Heart doi: 10.1136/heartjnl-2017-312809 contributor: fullname: GE Shields – volume: 12 start-page: e054558 year: 2022 ident: 9546_CR51 publication-title: BMJ Open doi: 10.1136/bmjopen-2021-054558 contributor: fullname: A Beleigoli – year: 2021 ident: 9546_CR2 publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001800.pub4 contributor: fullname: G Dibben – volume-title: Classifying Place of Death in Australian Mortality Statistics year: 2022 ident: 9546_CR34 contributor: fullname: Australian Bureau of Statistics – volume-title: National Efficient Price Determination 2022–2023- Price Weight Tables year: 2022 ident: 9546_CR33 contributor: fullname: Independent Hospital Pricing Authority – volume: 105 start-page: 122 year: 2019 ident: 9546_CR23 publication-title: Heart doi: 10.1136/heartjnl-2018-313189 contributor: fullname: R Maddison – volume: 20 start-page: 1 year: 2021 ident: 9546_CR43 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-021-01292-9 contributor: fullname: R Główczyńska |
SSID | ssj0017827 |
Score | 2.4236283 |
Snippet | Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding... Background Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established.... BackgroundTraditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established.... BACKGROUNDTraditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established.... Abstract Background Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 512 |
SubjectTerms | Analysis Australia Cardiac rehabilitation Cardiovascular disease Care and treatment Coronary Artery Disease - rehabilitation Coronary heart disease Coronary vessels Cost analysis Cost benefit analysis Cost-effectiveness Cost-Effectiveness Analysis Decision making Diagnosis Exercise Health services Health services utilization Heart failure Humans Hybrid Intervention Markov processes Methods Physical fitness Quality of Life Rehabilitation Sensitivity analysis Telemedicine Telerehabilitation Telerehabilitation - methods |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhp0IoTZu2TtKiQiCHIiLbsuzJLS0NSw89JZCb0JPuxSm7DmH_fUaPXdb00EsPvliykTWPb8YafSLkAiwXDp0vky4EJnQbGOgBmNV1aG0dlxNTle8vubgXPx-6h72jvmJNWKYHzhN3BQhovm9Mj3G5gFAPVoP0oW17BLtOZ_ZS3myTqbJ-gLjXb7fIDPJqjagWTzFo8IJOSPY8g6HE1v-3T94DpXnB5B4C3b4hr0voSG_ykI_JgR_fkqP8343m7UTvyHKxiXuwqE2St3RCWFnN2LgphqnURuICvdrQVNK5oWWdhi5Huvv7cU019ltPLNd8FLdIdaExOSH3tz_uvi9YOU6B2U6KiSH2gwMnQh84131oDSbS1tUWGstBB9OFAbNlb3kYvAMjDTdQO28cRuAimPY9ORwfR_-RUMG1tZKDj6uS3NTaS-Edxhr4PhAeKvJ1O7vqT2bNUCnbGKTKslAoC5VkoZ4r8i0KYNczMl6nG6gHquiB-pceVOQyik9Fu8RZsrpsL8ABR4YrddNjbteguxEVOZ_1RHuy8-atAqhiz2uFiWnPEbmhqciXXXN8Mtaojf7xKfapY_YFHMfyIevL7pPiWUADZooVGWaaNPvmecu4_J3YvtFnQkwqT__HLJ2RV02ygg7d4zk5nFZP_hNGVZP5nAzoBdjgIF8 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEB_07UUQ8Xurq0QQPEjYtE3TxIvsyi4PD4uIC3sLSZrou_St73VZ3n_vJM2rWwQPvTRpSTszv5nJTGYA3ivHeIfgS0UXAuWmDlQZqagzZahdGcOJKcv3Qiwv-der5ipvuG1zWuUeExNQd2sX98iP0TVoGWKnqj5f_6axa1SMruYWGvfhoCprKRdwcHp28e37FEdA_dfuj8pIcbxF7Ra7GVR4qYYLejtTR6lq_7_YfEc5zRMn72ii88fwKJuQ5GSk-RO45_un8HDcfyPjsaJnsFru4lks4hIHODKgetnMqnITNFeJiwUMzGZHUmrnjuR4DVn1ZNoF-UQMztsOdMz9yPBITC5n8hwuz89-fFnS3FaBukbwgaINoDrV8dAGxkwbaosOtetKpyrHlAm2CRK9Zu9YkL5TVlhmVdl526ElzoOtX8CiX_f-EAhnxjnBlI_RSWZL4wX3Hdoc-D7FvSrg4_7v6uuxeoZOXocUeqSFRlroRAt9W8BpJMA0M1a-TjfWm586C5JWaOD4trIt-mlchVI6o4QPdd2i8dOYpoAPkXw6yif-JWfyMQNccKx0pU9a9PEqhB1ewNFsJsqVmw_vGUBnud7qv1xYwLtpOD4Zc9V6v76Jc8rohSmGa3k58sv0SbEnkESPsQA546TZN89H-tWvVPUbsVNF5_LV_9f1Gh5Uib8bBMAjWAybG_8G7abBvs3C8QdL1hqP priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFD_M-SKIbH7WTYkg-CDVtE3THkFkiuMi6JMX9haSNHEXpFd7O-b97z1J2-vK9uBDX5qkbXI-f83JOQAv0XLRkPJNZeN9KnThU9Q1plZnvrBZ2E6MUb7f5GIpvpyVZ3swlTsaF3BzI7QL9aSW3c83f35vP5DAv48CX8u3G7JZoUZBTheWQqaXt-B2TpYxhHh9Ff92FcgaVtPBmRvHzYxTzOF_XVNfMVXzMMordun0AO6NDiU7GTjgEPZcex_uDn_j2HDI6AGsFttwMovZyA-W9WRsulmObkbOK7MhnYHutiwGem7ZuHvDVi3b_RN5xzT12_TpEAkyKkumx-QmD2F5-vn7p0U6FllIbSlFn5JHgA02wleec135whC8tk1mMbcctTelrwlDO8t97Ro00nCDWeNMQ3658KZ4BPvtunVPgAmurZUcXdir5CbTTgrXkAdCz0PhMIHX0-qqX0MuDRUxSC3VQAtFtFCRFuoygY-BALueIQ92vLHufqhRrBSSu-Oq3FSE2gT6rLYapfNFUZErVOoygVeBfCrwD62S1eOhA_rgkPdKnVSE-HJSQiKB41lPkjI7b54YQE1MqgiuVpzsOeYJvNg1h5Ehcq1164vQJwuYDDl9y-OBX3ZTChWCasKPCdQzTprNed7Srs5jDnDSpBig5tP_ePER3Mkjk5ekE49hv-8u3DNypXrzPMrHX9rcHqA priority: 102 providerName: Scholars Portal |
Title | Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37208666 https://www.proquest.com/docview/2827029992 https://search.proquest.com/docview/2816758905 https://pubmed.ncbi.nlm.nih.gov/PMC10198753 https://doaj.org/article/9091e72b796649f18ca96ef3370755a5 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aDkZhjH3PWxc0GOxhuJFtWbb21mQt2aBdKesIexGSLG2B1SmJS8l_v5NsZzV724NtsGQj-75-J92dAN4JQ1mFyjfmlXMxU5mLhSpFbFTiMpP45cQQ5XvGZ5fsyzyf7wDvc2FC0L7Ri8P699VhvfgVYiuvr8y4jxMbn59OkY2Ex9njXdhF-9v76N3aAdq8ok-PKfl4jRbN72CQ4iFyxuPbfbjv92YpeSiN-NcahaL9_6rmO7ZpGDd5xxCdPIKHHYIkR-1IH8OOrZ_Ag3b6jbRZRU9hMdv4VCxiAgMY0qB1WQ2KchNEq8T4-gVqtSEhsnNDuuUasqjJdhLkI1HYb93EbehHpx2J6qqZPIPLk-Nv01nc7aoQm5yzJkYIICpRMVc4SlXhMo3-tKkSI1JDhXI6dyU6zdZQV9pKaK6pFklldYVAnDmdPYe9elnbl0AYVcZwKqxfnKQ6UZYzWyHkwPcJZkUEH_q_K6_b4hkyOB0lly1ZJJJFBrLI2wgmngDbnr7wdbixXP2UHfmlQHxji1QX6KYx4ZLSKMGty7ICsU-u8gjee_JJL574l4zqsgxwwL7QlTwq0MVLUeuwCA4GPVGszLC5ZwDZifVaon9aUDTgIo3g7bbZP-lD1Wq7vPF9Eu-ECYpjedHyy_aTeraLoBxw0uCbhy0oA6Hod8_zr_7_0dewnwYxyFE3HsBes7qxbxBSNXqEcjQvRnBvcnx2foHX6dfvnz-NwgQFnk9ZieeLyY9RkLQ_eP8pcg |
link.rule.ids | 230,314,727,780,784,864,885,2102,12056,21388,24318,27924,27925,31719,31720,33744,33745,38516,43310,43805,43895,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI_g9gASmvgchQFBQuIBRUvbNG14QRvadMA4IbRJe4vSfMC99MZdp-n--9lp7liFxENfmrRKa_tnO3ZsQt4py4UD8GXShcCEKQNTplHMmjyUNsdwYszyncnpufh6UV2kDbdVSqvcYGIEarewuEd-AK5BzQE7VfHp8g_DrlEYXU0tNO6SHaycXk3IztHx7MfPbRwB9F-9OSrTyIMVaDfsZlDApSoh2fVIHcWq_f9i8y3lNE6cvKWJTh6S3WRC0sOB5o_IHd89Jg-G_Tc6HCt6QubTNZ7FojZygKU9qJflqCo3BXOVWixgYJZrGlM71zTFa-i8o9tdkI_UwLxVz4bcjwSP1KRyJk_J-cnx2ecpS20VmK2k6BnYAMopJ0IdODd1KFtwqK3LrSosVya0VWjAa_aWh8Y71cqWtyp3vnVgiYvQls_IpFt0_jmhghtrJVceo5O8zY2XwjuwOeB9SniVkQ-bv6svh-oZOnodjdQDLTTQQkda6OuMHCEBtjOx8nW8sVj-0kmQtAIDx9dFW4OfJlTIG2uU9KEsazB-KlNl5D2ST6N8wl-yJh0zgAVjpSt9WIOPVwDsiIzsj2aCXNnx8IYBdJLrlf7LhRl5ux3GJzFXrfOLK5yToxemOKxlb-CX7SdhT6AGPMaMNCNOGn3zeKSb_45VvwE7FTqXL_6_rjfk3vTs-6k-_TL79pLcLyKvVwCG-2TSL6_8K7Ch-vZ1EpQbo6cddw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkapKqOJZAgWMhMQBpXESx4m5lcJqeVU9UKk3y3ZsWIlmV7tbVfvvO3acpRE3DrnETuRkvnnZ488Ab4WhrEXjm_LWuZSp0qVCNSI1Knelyf1yYqjyPeXTc_b1orqIVZWrWFbZGT076v5cHnWz36G2cnFpsqFOLDv7cYIwEj7Ozhaty-7CvapElA2ZelxBQM9XD5tkGp6t0K_5cwwKvETFeHq9B7v-hJaGB4LEvz4pUPf_a6Bveahx9eQtdzR5APsxjiTH_Xgfwh3bPYL7_SQc6fcWPYbZdOM3ZBETYGDIGn3MckTNTTBmJcazGKjlhoT6zg2JizZk1pHtVMgHorDfap32BSDRRhIVOU2ewPnk88-TaRrPVkhNxdk6xUBAtKJlrnaUqtqVGrNq0-ZGFIYK5XTlGkydraGusa3QXFMt8tbqFsNx5nT5FHa6eWefAWFUGcOpsH6JkupcWc5si4EHvk8wKxJ4P_xduegpNGRIPRoue7FIFIsMYpHXCXz0Atj29PTX4cZ8-UtGEEiBUY6tC11jssaEyxujBLeuLGuMgCpVJfDOi096JcW_ZFTca4AD9nRX8rjGRK9A28MSOBz1ROUy4-YBADIq90pillpTdOOiSODNttk_6QvWOju_8n1yn4oJimM56PGy_aQBdgk0IySNvnncgpoQqL8H5D___0dfw-7Zp4n8_uX02wvYK4JGVGgsD2FnvbyyLzHGWutXQZluABYQJuM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hybrid+cardiac+telerehabilitation+for+coronary+artery+disease+in+Australia%3A+a+cost-effectiveness+analysis&rft.jtitle=BMC+health+services+research&rft.au=Senanayake%2C+Sameera&rft.au=Halahakone%2C+Ureni&rft.au=Abell%2C+Bridget&rft.au=Kularatna%2C+Sanjeewa&rft.date=2023-05-20&rft.eissn=1472-6963&rft.volume=23&rft.issue=1&rft.spage=512&rft.epage=512&rft_id=info:doi/10.1186%2Fs12913-023-09546-w&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6963&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6963&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6963&client=summon |